Q2 Earnings Forecast for ELDN Issued By Noble Financial
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Analysts at Noble Financial issued their Q2 2025 EPS estimates for shares of Eledon Pharmaceuticals in a report released on Monday, May 19th. Noble Financial analyst R. Leboyer expects that the company will earn ($0.22) per share for the quarter. The consensus estimate for Eledon Pharmaceuticals’ current […]
